CPRC
ABT icon

Consolidated Portfolio Review Corp’s Abbott ABT Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,751
Closed -$502K – 37
2025
Q3 		$502K Buy
3,751
+2,052
+121% +$269K 0.06% 269
2025
Q2 		$231K Buy
1,699
+51
+3% +$6.72K 0.03% 401
2025
Q1 		$219K Sell
1,648
-1,018
-38% -$130K 0.04% 348
2024
Q4 		$302K Buy
2,666
+197
+8% +$22.8K 0.05% 296
2024
Q3 		$281K Buy
+2,469
New +$271K 0.06% 257

Other funds holding ABT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Consolidated Portfolio Review Corp's ABT Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Abbott (ABT) in Q4 2025, closing a stake of 3,751 shares — an estimated $502K sold.

Consolidated Portfolio Review Corp first reported a position in ABT in Q3 2024 and held it in 5 quarters. The position peaked at $502K in Q3 2025. 3,284 funds tracked by Wall St. Rank hold ABT as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Abbott position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 3,751 Abbott shares in Q4 2025, an estimated $502K.
  • Consolidated Portfolio Review Corp first reported a position in Abbott in Q3 2024 and held it in 5 quarters.
  • Consolidated Portfolio Review Corp's Abbott position peaked at $502K in Q3 2025.
  • 3,284 funds tracked by Wall St. Rank held Abbott as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.